Skip to content

A Behavioral Intervention for Reducing Obesity

A Behavioral Intervention for Reducing Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00892788
Enrollment
56
Registered
2009-05-05
Start date
2009-04-30
Completion date
2010-07-31
Last updated
2019-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

Overweight, Obesity, Contingency Management

Brief summary

This study will examine a contingency management (CM) intervention designed to provide incentives for losing weight versus participating in a manual-guided behavioral weight loss intervention alone. Participants in the CM condition will earn the opportunity to win prizes by losing weight and completing activities that contribute to weight loss, such as keeping daily food and physical activity diaries, choosing healthy foods, exercising, and using other weight loss strategies. The investigators will determine if the CM improves weight loss relative to the usual care manual-guided intervention alone.

Interventions

BEHAVIORALcontingency management

Prize-based contingency management for weight loss

once weekly counseling sessions with research staff

Sponsors

UCHC/Storrs and Regional Campus Incentive Grants
CollaboratorUNKNOWN
UConn Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 65 years * body mass index in kg/m2 (BMI) between 30.0 and 39.9 * seated blood pressure of 100/60-140/90 mmHg * ability to speak English and read at the 6th grade level * willingness to be randomly assigned to one of two groups

Exclusion criteria

* any serious acute or chronic medical problems that may impact dietary or exercise regimens or impact weight loss * psychiatric exclusions

Design outcomes

Primary

MeasureTime frame
absolute and relative weight lossWeeks 1-12
changes in waist circumferenceWeek 1 and Week 12
proportion of participants achieving clinically significant weight loss (5% or more of baseline weight)Week 1 and Week 12

Secondary

MeasureTime frame
indices of treatment retentionWeeks 1-12
changes on measures of diet quality, physical activity, and physiological parameters such as blood pressure, lipoproteins, insulin, and glucose levelsWeek 1 and Week 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026